NCT04257500View on ClinicalTrials.gov

Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/obese Women with PCOS

PHASE4RecruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 3, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

Etonogestrel/ethinyl estradiol vaginal ring

16 weeks of continuous use of contraceptive vaginal ring

Trial Locations (1)

19104

RECRUITING

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Andrea Roe, MD, MPH

OTHER